Navigation Links
Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid

new SEROQUEL® sustained release formulation studies presented at the congress show that patients who are currently receiving original formulation quetiapine, or who are inadequately treated with another antipsychotic agent, could be easily switched to SEROQUEL® sustained release formulation. Among clinically stable patients who switched from original formulation quetiapine, there were no significant differences between SEROQUEL sustained release formulation and the original formulation quetiapine in PANSS total scores after six weeks’ treatment (mean PANSS total score at day 42 was 55.4 and 54.8 for the sustained release formulation and the original formulation respectively) and the incidence of adverse events was similar (Study 146). Among patients who switched to SEROQUEL® sustained release formulation from other antipsychotics, 62.8 percent achieved improved clinical benefit (based on CGI-CB scores) regardless of the reason for switching (insufficient efficacy or intolerability of initial treatment, Study 147).

Based on these data and data from other trials, regulatory filings for the treatment of schizophrenia with SEROQUEL® sustained release formulation were submitted to the authorities in the US, EU and other markets in 2006. Beyond schizophrenia, ongoing clinical studies of SEROQUEL® sustained release formulation cover bipolar disorder, major depressive disorder and generalised anxiety disorder. SEROQUEL® (original formulation quetiapine) is the number one prescribed atypical antipsychotic in the United States and global sales for SEROQUEL® reached $3.4 billion in 2006. It is licensed in 85 countries for the treatment of schizophrenia, in 73 countries for the treatment of mania associated with bipolar disorder, and in October 2006 it was approved in the US by the FDA for the treatment of bipolar depression. It is estimated that more than 19 million patients have used SEROQUEL® worldwide since its launch in 1997.'"/>




Page: 1 2 3 4

Related medicine technology :

1. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
2. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
3. OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation
4. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
5. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
6. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
7. Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
10. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
(Date:8/27/2014)... Varian Medical Systems (NYSE: VAR) today broke ground on ... Lake City manufacturing facility and allow for the ... to ultimately create 1,000 new full time jobs ... " Utah is home to hardworking ... can be credited with Varian,s success in the manufacturing of ...
(Date:8/27/2014)... DALLAS , August 27, 2014 ... "Dental Equipment Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, ... 2019" published by MarketsandMarkets, the global Dental Equipment Market ... from $5,416.3 million in 2014, growing at a ... Browse 95 market data tables and 61 ...
(Date:8/27/2014)... York , August 27, 2014 ... United States  Laparoscopes Market Outlook to 2020. ... provides key market data on the United States ... of US dollars, volume (in units) and average prices ... Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic ...
Breaking Medicine Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... , CORALVILLE, Iowa, Dec. 16 Vivakor, ... Development agreement with Baker Consulting out of Walnut Creek, ... of South Florida. Baker Consulting has been retained ... assisting the company with its recently reported acquisition strategy. ...
... Dec. 16 Naurex Inc., a new clinical stage company ... on its novel GFPA NMDA receptor modulators, today announced that ... lead compound GLYX-13 and has successfully dosed the first subjects ... agonist (GFPA) selective modulator of the NMDA receptor, is initially ...
Cached Medicine Technology:Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3
(Date:8/27/2014)... 28, 2014 BRIC Laparoscopes Market Outlook ... provides key market data on the BRIC Laparoscopes market. ... volume (in units) and average prices (in US dollars) ... and Flexible Tip Video Laparoscopes), Robotic Surgical Systems and ... of advantages to the patient with laparoscopic surgery versus ...
(Date:8/27/2014)... play a key role in inflaming blood vessels and ... study at UCLA demonstrates that they may also contribute ... the small blood vessels in the lungs. , Using ... mimicking part of the main protein in high-density lipoprotein ... production of oxidized lipids in pulmonary hypertension. They also ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Dr. ... Vision Center see multitudes of patients suffering from impaired ... and Cataract vision correction surgery . Recently, Dr. ... glaucoma information during an eye exam and also online. ... the top five myths about glaucoma. , 1)    Myth: People ...
(Date:8/27/2014)... 27, 2014 The federal judge overseeing ... has extended the deadline for plaintiffs to enroll in ... Order issued by U.S. District Judge David Katz of ... in the DePuy ASR Settlement Program must do so ... ASR Hip Implant Products Liability Litigation – MDL 2197) ...
(Date:8/27/2014)... The extensive polling of 970 ... research group Black Book Rankings uncovers several alarming ... supplied or built to care for even a ... annual survey to gain stakeholder insight into the ... and emergency preparedness systems,” said Doug Brown, Managing ...
Breaking Medicine News(10 mins):Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 2Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 3Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 4Health News:Protein in 'good cholesterol' may be a key to treating pulmonary hypertension 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4
... the Doubletree Hotel in Oak Brook ... 23 The Perinatal Nursing Advisory Council and the March of ... lactation consultants, and the community to the March of Dimes ... Oak Brook, Illinois. All healthcare professionals caring for moms ...
... retinoid tretinoin not the culprit , , FRIDAY, Jan. 23 (HealthDay ... that was tried as a possible skin cancer preventative in ... of several veterans participating in that research. , The ... risk of death was seen in those using retinoid tretinoin ...
... contradicts belief that death rate associated with condition has ... death rate for patients with acute respiratory distress syndrome ... that contradicts the common belief there,s been a steady ... , The researchers reviewed studies conducted between 1984 and ...
... inflammatory bowel disease have higher concentrations of folate in their blood than ... the University of California, San Francisco and UC Berkeley. The findings bring ... to folate - also known as folic acid - deficiency. , ... ...
... Ohio, Jan. 23 Patricia A. Furlong, Founding ... (PPMD), the largest non-profit organization in the United ... muscular dystrophy (Duchenne), announced the one year anniversary ... resources and needs of the Duchenne and Becker ...
... 23 Heartland Information Services,( www.heartlandis.com ), headquartered ... outsourced transcription companies in a report released in ... firm,( www.KLASresearch.com ). In their report, Top 20 ... 2008, Heartland moved up for the third year ...
Cached Medicine News:Health News:March of Dimes 34th Annual Perinatal Conference For Nurses, Health Educators, Social Workers and Other Healthcare Pros Caring for Moms and Babies 2Health News:Acne Cream Not Linked to Raised Death Risk 2Health News:Acne Cream Not Linked to Raised Death Risk 3Health News:Acute Respiratory Distress Syndrome as Deadly as Ever 2Health News:Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds 2Health News:Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds 3Health News:Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds 4Health News:DuchenneConnect Celebrates One Year Anniversary 2Health News:DuchenneConnect Celebrates One Year Anniversary 3Health News:DuchenneConnect Celebrates One Year Anniversary 4Health News:Heartland Information Services Moves Up to 2nd Place in National Survey for Outsourced Transcription 2
The Onar®Lp test system is an in vitro test for the qualitative diagnosis of legionella in clinical samples....
The Onar®Lp -QP test system is an in vitro test for the quantitative diagnosis of legionella in clinical samples....
Designed for OSA patients who have difficulty with conventional CPAP therapy, the ResMed SULLIVAN Comfort system is a solution for those who need an alternative to CPAP....
... an approach to treatment that ... pressure range to 25 cm ... treat patients with severe OSA. ... integrated humidification and built-in Encore® ...
Medicine Products: